TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2016

BAK is a predictive and prognostic biomarker for the therapeutic effect of docetaxel treatment in patients with advanced gastric cancer.

Tomohiro Kubo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.